Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 8
2003 11
2004 12
2005 12
2006 10
2007 8
2008 7
2009 8
2010 12
2011 9
2012 8
2013 9
2014 4
2015 7
2016 6
2017 7
2018 6
2019 9
2020 6
2021 9
2022 7
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Results by year

Filters applied: . Clear all
Page 1
Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.
Higashi-Kuwata N, Tsuji K, Hayashi H, Bulut H, Kiso M, Imai M, Ogata-Aoki H, Ishii T, Kobayakawa T, Nakano K, Takamune N, Kishimoto N, Hattori SI, Das D, Uemura Y, Shimizu Y, Aoki M, Hasegawa K, Suzuki S, Nishiyama A, Saruwatari J, Shimizu Y, Sukenaga Y, Takamatsu Y, Tsuchiya K, Maeda K, Yoshimura K, Iida S, Ozono S, Suzuki T, Okamura T, Misumi S, Kawaoka Y, Tamamura H, Mitsuya H. Higashi-Kuwata N, et al. Among authors: tamamura h. Nat Commun. 2023 Feb 25;14(1):1076. doi: 10.1038/s41467-023-36729-0. Nat Commun. 2023. PMID: 36841831 Free PMC article.
Chloroalkene dipeptide isosteres as peptidomimetics.
Kobayakawa T, Tamamura H. Kobayakawa T, et al. Among authors: tamamura h. Methods Enzymol. 2021;656:191-239. doi: 10.1016/bs.mie.2021.04.015. Epub 2021 May 21. Methods Enzymol. 2021. PMID: 34325787
Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins.
Kobayakawa T, Yokoyama M, Tsuji K, Fujino M, Kurakami M, Onishi T, Boku S, Ishii T, Miura Y, Shinohara K, Kishihara Y, Ohashi N, Kotani O, Murakami T, Sato H, Tamamura H. Kobayakawa T, et al. Among authors: tamamura h. RSC Adv. 2023 Jan 12;13(3):2156-2167. doi: 10.1039/d2ra06837k. eCollection 2023 Jan 6. RSC Adv. 2023. PMID: 36712613 Free PMC article.
Bivalent HIV-1 fusion inhibitors based on peptidomimetics.
Kobayakawa T, Ebihara K, Tsuji K, Kawada T, Fujino M, Honda Y, Ohashi N, Murakami T, Tamamura H. Kobayakawa T, et al. Among authors: tamamura h. Bioorg Med Chem. 2020 Dec 15;28(24):115812. doi: 10.1016/j.bmc.2020.115812. Epub 2020 Oct 9. Bioorg Med Chem. 2020. PMID: 33157478
Small-Molecule Anti-HIV-1 Agents Based on HIV-1 Capsid Proteins.
Kobayakawa T, Yokoyama M, Tsuji K, Fujino M, Kurakami M, Boku S, Nakayama M, Kaneko M, Ohashi N, Kotani O, Murakami T, Sato H, Tamamura H. Kobayakawa T, et al. Among authors: tamamura h. Biomolecules. 2021 Feb 3;11(2):208. doi: 10.3390/biom11020208. Biomolecules. 2021. PMID: 33546092 Free PMC article.
Potent and biostable inhibitors of the main protease of SARS-CoV-2.
Tsuji K, Ishii T, Kobayakawa T, Higashi-Kuwata N, Azuma C, Nakayama M, Onishi T, Nakano H, Wada N, Hori M, Shinohara K, Miura Y, Kawada T, Hayashi H, Hattori SI, Bulut H, Das D, Takamune N, Kishimoto N, Saruwatari J, Okamura T, Nakano K, Misumi S, Mitsuya H, Tamamura H. Tsuji K, et al. Among authors: tamamura h. iScience. 2022 Nov 18;25(11):105365. doi: 10.1016/j.isci.2022.105365. Epub 2022 Nov 1. iScience. 2022. PMID: 36338434 Free PMC article.
173 results